Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6SH4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,595
Award facts
- Contract value 100% obligated
- $26,595.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,595.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on January 16, 2026, with completion targeted for January 20, 2026. This competitive award, which includes no set-aside designation, is being fulfilled from the vendor's place of business in Conshohocken, Pennsylvania. REPATHA (evolocumab) is a PCSK9 inhibitor used for cardiovascular disease management and represents one of many specialty pharmaceutical products that AmerisourceBergen supplies through its federal contracts to support military healthcare requirements.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999 million through December 2031. This master IDC functions as a global pharmaceutical supply vehicle enabling the company to provide a comprehensive portfolio of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. The delivery order structure and firm fixed pricing reflect the efficient procurement methodology under this comprehensive contract vehicle that streamlines pharmaceutical sourcing for federal military medical systems.
Quick answers
Who was awarded contract SPE2DR26F6SH4?
SPE2DR26F6SH4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F6SH4 worth?
The government has obligated $26,595 on SPE2DR26F6SH4.
Is contract SPE2DR26F6SH4 an order under another contract?
Yes. SPE2DR26F6SH4 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SH4 competed?
The extent of competition for SPE2DR26F6SH4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award